Nowadays Biophilia Tracker X4 max therapy can work for many problems. how is can help on Depression?

Depression is the most common disease of affective disorders, which is part of the field of psychiatry. Depression is defined more as a mood disorder than as a thinking disorder, limiting the normal functioning of individuals, and ranging from an extremely mild to a severe form.

This negative emotional state can persist for a short period of time or for a longer period, with mild, moderate or severe intensity, which can seriously damage one's health. Globally, depression is a leading cause of premature death, along with cardiovascular disease and cancer, limiting the individual from activity, and with a significant risk of suicide. Almost 800,000 individuals die each year from suicide. Depression is found in 5% of Europeans and 25% are likely to experience a depressive episode at least once in their lives. By 2030, it is estimated that depression will become one of the most significant mental and behavioral disorders, as it currently occupies a second place in the ranking of diseases worldwide, following cardiovascular diseases.

Approximately 80% of individuals who suffer from a mental disease do not receive treatment, especially in poorly developed countries. The most common treatments used in depression are pharmacological medication with antidepressants, or their combination with psychotherapy or psychotherapy as singular treatment. Each employed treatment was found to be useful, but for patients with severe depression, a high dropout rate and low remission were found, and clinically significant differences were observed between antidepressants and placebo. Consequently, patients having mild or moderate depression seek alternative treatments.

Biophilia Tracker X4 Bioresonance therapy has been successfully used as an alternative therapy in various ailments, by many practitioners worldwide. Several clinical, physical and organic studies have been completed by global research groups that demonstrate the effectiveness of the bioresonance approach in situations such as allergies, rheumatic diseases, respiratory diseases and many painful syndromes. In the present study, the aim was to determine whether this new method of therapy is a viable alternative to antidepressants from the selective serotonin reuptake inhibitor class for patients diagnosed with recurrent moderate or mild depressive disorder by decreasing the level of depression quantified with the Hamilton Scale. In addition, the aim was to verify the null hypothesis (H0), which holds that the applied bioresonance therapy does not accelerate the healing process in patients with recurrent moderate and mild depressive disorder, compared with antidepressant medication from the selective serotonin reuptake inhibitor class. 

Method

For all patients, the decrease in the level of depression, within a period of maximum 2 months, from the first to the fifth session, was monitored.

The bioresonance treatment consisted of 20 min and was conducted using a Biophilia Tracker bioresonance device. The bioresonance device automatically displays on the screen of the device the 16 values of the energy field, eight at the beginning and eight at the end of each bioresonance session. When commencing with the therapy, the conductance between the hands and feet is automatically measured and displayed. The principle of basic bioresonance therapy with the Biophilia Tracker device includes endogenous therapy, by means of hand and foot electrodes, on the palms and fingers and soles, respectively, where the reflexogenic areas of the organs are provided, being considered the fundamental principle of therapy with physical bioresonance. Through these measurements the specific reaction of the patient to the applied therapy was evaluated, showing the mental state in which the patient was before and at the end of each treatment session.